We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+10.34%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$5.32B
AUM Growth
+$623M
(+13%)
Cap. Flow
+$473M
Cap. Flow
% of AUM
8.88%
Top 10 Holdings %
Top 10 Hldgs %
31.02%
Holding
1,563
New
308
Increased
332
Reduced
859
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$43.7M |
| 2 |
American Tower
AMT
|
+$34.7M |
| 3 |
Crown Castle
CCI
|
+$21.3M |
| 4 |
CD
Chindata Group Holdings Limited American Depositary Shares
CD
|
+$19.1M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$13.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$80.9M |
| 2 |
Microsoft
MSFT
|
+$63.9M |
| 3 |
Amazon
AMZN
|
+$61.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$26.4M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$24.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 18.33% |
| 2 | Technology | 16.44% |
| 3 | Consumer Discretionary | 8.8% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
1276
DELISTED
Radius Health, Inc.
RDUS
| $54K | ﹤0.01% |
3,012
-190
| -6% | -$2.85K |
|
1277
Booz Allen Hamilton
BAH
$8.8B
| $53K | ﹤0.01% |
605
+289
| +91% | +$24.6K |
|
|
CYBR
1278
DELISTED
CyberArk
CYBR
| $53K | ﹤0.01% |
+329
| New | +$38.3K |
|
1279
Zillow
ZG
$7.74B
| $52K | ﹤0.01% |
+384
| New | +$43.3K |
|
1280
Ambev
ABEV
$48.4B
| $50K | ﹤0.01% |
16,227
+2,235
| +16% | +$6.03K |
|
|
CEQP
1281
DELISTED
Crestwood Equity Partners LP
CEQP
| $50K | ﹤0.01% |
2,627
-377
| -13% | -$6.17K |
|
|
AGEN
1282
Agenus
AGEN
$275M
| $49K | ﹤0.01% |
789
+404
| +105% | +$30K |
|
|
AIV
1283
Aimco
AIV
$375M
| $49K | ﹤0.01% |
9,284
-68,059
| -88% | -$302K |
|
1284
Enanta Pharmaceuticals
ENTA
$367M
| $49K | ﹤0.01% |
1,164
+262
| +29% | +$11.5K |
|
1285
Vale
VALE
$62.6B
| $49K | ﹤0.01% |
2,933
-643
| -18% | -$8.57K |
|
1286
Viking Therapeutics
VKTX
$3.93B
| $47K | ﹤0.01% |
8,372
+2,597
| +45% | +$15.7K |
|
|
EGRX
1287
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $47K | ﹤0.01% |
1,016
+132
| +15% | +$6.17K |
|
|
ATNX
1288
DELISTED
Athenex, Inc. Common Stock
ATNX
| $47K | ﹤0.01% |
213
+102
| +92% | +$25.1K |
|
1289
America Movil
AMX
$77.2B
| $45K | ﹤0.01% |
+3,074
| New | +$41.7K |
|
1290
Zentalis Pharmaceuticals
ZNTL
$329M
| $45K | ﹤0.01% |
+874
| New | +$39.4K |
|
|
SPPI
1291
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $45K | ﹤0.01% |
13,130
+7,022
| +115% | +$28.9K |
|
1292
Rigel Pharmaceuticals
RIGL
$712M
| $44K | ﹤0.01% |
+1,265
| New | +$36.6K |
|
1293
United Microelectronic
UMC
$43.6B
| $44K | ﹤0.01% |
+5,163
| New | +$33.7K |
|
|
FLXN
1294
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $44K | ﹤0.01% |
3,783
+492
| +15% | +$5.72K |
|
|
CEO
1295
DELISTED
CNOOC Limited
CEO
| $44K | ﹤0.01% |
481
+143
| +42% | +$14.1K |
|
|
CHL
1296
DELISTED
China Mobile Limited
CHL
| $44K | ﹤0.01% |
1,550
+398
| +35% | +$12.3K |
|
1297
Kiniksa Pharmaceuticals
KNSA
$6.11B
| $42K | ﹤0.01% |
+2,373
| New | +$41.7K |
|
1298
Travere Therapeutics
TVTX
$5.2B
| $42K | ﹤0.01% |
1,549
-348
| -18% | -$8.13K |
|
|
FMTX
1299
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $42K | ﹤0.01% |
+1,201
| New | +$52.3K |
|
1300
Rhythm Pharmaceuticals
RYTM
$7.41B
| $41K | ﹤0.01% |
1,383
+432
| +45% | +$11K |
|
Similar funds
SAM
Pacer Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Pacer Advisors held 1,563 positions worth $5.32B, up 13% from $4.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Pacer Advisors deployed $473M of net new capital in Q4 2020, opening 308 new positions and adding to 332 existing holdings. Its largest new stake was Chindata Group Holdings Limited American Depositary Shares: 1,166,530 shares worth $27.9M.
By sector, the portfolio is most concentrated in Real Estate at 18% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $80.9M trimmed.
- Pacer Advisors's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 1,166,530 shares worth $27.9M.
- Pacer Advisors added most to Equinix in Q4 2020, an estimated $43.7M increase.
- Pacer Advisors's biggest Q4 2020 reduction was Apple, cutting an estimated $80.9M.
- Pacer Advisors fully exited INDUS Realty Trust, Inc. (MD) Common Stock in Q4 2020, selling an estimated $1.83M.
- Pacer Advisors's ten largest holdings make up 31% of its $5.32B portfolio in Q4 2020.
- Pacer Advisors opened 308 new positions and closed 60 in Q4 2020.
- Pacer Advisors's portfolio value rose 13% quarter-over-quarter to $5.32B.
Based on Pacer Advisors's 13F filing for Q4 2020, filed 20 Jan 2021.